Search research articles
Contact Us
Filters
Showing results (71-80 of 123) with videos related to
Page
of 13
Sort By:
Annals of Internal Medicine
|
March 22, 2006
Cost-effectiveness of preventive strategies for women with a BRCA1 or a BRCA2 mutation
Kristin Anderson, Judith S Jacobson, Daniel F Heitjan, et al.
BJU International
|
April 19, 2008
Is the biopsy Gleason score important in predicting outcomes for patients after radical prostatectomy once the pathological Gleason score is known?
Manish A Vira, Thomas Guzzo, Daniel F Heitjan, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 19, 2018
Glucocorticoid Receptor Mutations and Hypersensitivity to Endogenous and Exogenous Glucocorticoids
Richard J Santen, Christine M Jewell, Wei Yue, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2002
Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study
Alfred I Neugut, Aaron T Fleischauer, Vijaya Sundararajan, et al.
Annals of Internal Medicine
|
February 4, 2010
Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial
Robert A Schnoll, Freda Patterson, E Paul Wileyto, et al.
Pediatric Obesity
|
July 17, 2023
Electronic phenotypes to distinguish clinician attention to high body mass index, hypertension, lipid disorders, fatty liver and diabetes in pediatric primary care: Diagnostic accuracy of electronic phenotypes compared to masked comprehensive chart review
Christy B Turer, Jenny J Park, Olga T Gupta, et al.
Cancer Biology & Therapy
|
January 26, 2008
Pilot study of DCE-MRI to predict progression-free survival with sorafenib therapy in renal cell carcinoma
Keith T Flaherty, Mark A Rosen, Daniel F Heitjan, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 14, 2020
Underlying Breast Cancer Risk and Menopausal Hormone Therapy
Richard J Santen, Daniel F Heitjan, Anne Gompel, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 4, 2020
Approach to Managing a Postmenopausal Patient
Richard J Santen, Daniel F Heitjan, Anne Gompel, et al.
Annals of Surgical Oncology
|
September 1, 2005
Suppression of beta-catenin by antisense oligomers augments tumor response to isolated limb perfusion in a rodent model of adenomatous polyposis coli-mutant colon cancer
Robert J Canter, Susan B Kesmodel, Daniel F Heitjan, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 123) with videos related to
Sort By:
Page
of 13
Annals of Internal Medicine
|
March 22, 2006
Cost-effectiveness of preventive strategies for women with a BRCA1 or a BRCA2 mutation
Kristin Anderson, Judith S Jacobson, Daniel F Heitjan, et al.
BJU International
|
April 19, 2008
Is the biopsy Gleason score important in predicting outcomes for patients after radical prostatectomy once the pathological Gleason score is known?
Manish A Vira, Thomas Guzzo, Daniel F Heitjan, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 19, 2018
Glucocorticoid Receptor Mutations and Hypersensitivity to Endogenous and Exogenous Glucocorticoids
Richard J Santen, Christine M Jewell, Wei Yue, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2002
Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study
Alfred I Neugut, Aaron T Fleischauer, Vijaya Sundararajan, et al.
Annals of Internal Medicine
|
February 4, 2010
Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial
Robert A Schnoll, Freda Patterson, E Paul Wileyto, et al.
Pediatric Obesity
|
July 17, 2023
Electronic phenotypes to distinguish clinician attention to high body mass index, hypertension, lipid disorders, fatty liver and diabetes in pediatric primary care: Diagnostic accuracy of electronic phenotypes compared to masked comprehensive chart review
Christy B Turer, Jenny J Park, Olga T Gupta, et al.
Cancer Biology & Therapy
|
January 26, 2008
Pilot study of DCE-MRI to predict progression-free survival with sorafenib therapy in renal cell carcinoma
Keith T Flaherty, Mark A Rosen, Daniel F Heitjan, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 14, 2020
Underlying Breast Cancer Risk and Menopausal Hormone Therapy
Richard J Santen, Daniel F Heitjan, Anne Gompel, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 4, 2020
Approach to Managing a Postmenopausal Patient
Richard J Santen, Daniel F Heitjan, Anne Gompel, et al.
Annals of Surgical Oncology
|
September 1, 2005
Suppression of beta-catenin by antisense oligomers augments tumor response to isolated limb perfusion in a rodent model of adenomatous polyposis coli-mutant colon cancer
Robert J Canter, Susan B Kesmodel, Daniel F Heitjan, et al.
Page
of 13